Investopedia
10 Nov 2025, 14:10 UTC · 50w ago
Verdict
Headline takes no side. We score MTSR −0.80 across five claims — strongly bearish.
−0.80strongly bearish
More negative than 92% of ticker scores this week
Scored by the NIS engine · methodology.
What the story claims
5 claims · scored −1 bearish … +1 bullish
The U.S. Senate passed a key 60-40 procedural vote that paves the way to end the longest government shutdown in U.S. history after more than 40 days.
More positive than 99% of claims this week
President Trump proposed issuing $2,000 'dividend' payments to Americans funded by tariff revenues.
Continue reading
5 related stories
Search tags
More positive than 98% of claims this week
Trump's tariff policies are currently being challenged in a Supreme Court case that questions his authority to issue the import taxes.
More negative than 95% of claims this week
The government shutdown has frozen economic reports from federal statistical agencies, putting upcoming inflation and retail sales data at risk.
So whatA data blackout forces the Fed and investors to fly blind on inflation and growth metrics, increasing market volatility and the risk of policy missteps until the data flow resumes.
More negative than 91% of claims this week
Metsera shares are plunging after announcing it will be acquired by Pfizer following a bidding war with Novo Nordisk.
More positive than 62% of claims this week
Which stocks this story touches
More negative than 92% of ticker scores this week
Shares are plunging following the announcement of its acquisition.
More positive than 53% of ticker scores this week
The company is expected to report a big revenue jump in its quarterly results.
More negative than 68% of ticker scores this week
The company lost the bidding war to acquire Metsera.
More positive than 45% of ticker scores this week
The company is acquiring Metsera after a bidding war.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
24/7 Wall Street
7h ago
More positive than 54% of relationship scores this week
[mutual] Pfizer and Novo Nordisk engaged in a bidding war to acquire Metsera.
More positive than 7% of relationship scores this week
[mutual] Novo Nordisk was a bidder for Metsera, competing against Pfizer.
−15.2%
Price agrees with the score
$70.50 vs $83.18 close before publication (Nov 7) · not market-adjusted
MTSR chart →
